US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

BD ChloraPrep" Triple Swabsticks

Reason Lack of Assurance of Sterlity

CareFusion 213, LLC NDC 54365-401-29 D-0243-2026
Class II · Moderate risk Ongoing

Oxycodone and Acetaminophen CII Tablets USP

Reason Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC NDC 0406-0522-01 D-0255-2026
Class II · Moderate risk Ongoing

Oxycodone and Acetaminophen CII Tablets USP

Reason Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC NDC 0406-0523-01 D-0254-2026
Class II · Moderate risk Ongoing

Noxafil Powdermix

Reason Presence of particulate matter: potential presence of metal particulates in the product.

Merck Sharp & Dohme LLC NDC 0085-2224-02 D-0242-2026
Class II · Moderate risk Ongoing

Merck Emend

Reason Presence of particulate matter: potential presence of metal particulates in the product.

Merck Sharp & Dohme LLC NDC 0006-3066-03 D-0241-2026
Class II · Moderate risk Ongoing

Ciclopirox Shampoo

Reason Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Sun Pharma /Taro NDC 51672-1351-08 D-0240-2026
Class II · Moderate risk Ongoing

ORL Kids Natural Toothpaste

Reason cGMP Deviations

Signature Formulations, LLC D-0253-2026
Class II · Moderate risk Ongoing

ORL Kids Mouthwash

Reason cGMP Deviations

Signature Formulations, LLC D-0252-2026
Class II · Moderate risk Ongoing

Baclofen Tablets USP

Reason Presence of Foreign Tablets/Capsules

Golden State Medical Supply Inc. NDC 51407-973-10 D-0235-2026
Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules

Reason CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Breckenridge Pharmaceutical, Inc. NDC 51991-748-10 D-0216-2026
Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Capsules

Reason CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Breckenridge Pharmaceutical, Inc. NDC 82009-032-10 D-0215-2026
Class II · Moderate risk Ongoing

Ondansetron ODT Tablets

Reason Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Preferred Pharmaceuticals, Inc. NDC 68788-8666-01 D-0239-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0226-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0225-2026
Class II · Moderate risk Ongoing

Cinacalcet Hydrochloride Tablets

Reason CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Cipla USA, Inc. D-0224-2026
Class II · Moderate risk Ongoing

Ganirelix Acetate Injection

Reason Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Lupin Pharmaceuticals Inc. NDC 70748-274-01 D-0220-2026
Class II · Moderate risk Ongoing

Walgreens Saline Nasal Spray WITH XYLITOL

Reason Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis

Medical Products Laboratories, Inc. NDC 0363-3114-01 D-0179-2026
Class II · Moderate risk Ongoing

Sertraline Hydrochloride Tablets USP

Reason Defective container - seal not adhering to bottles

Lupin Pharmaceuticals Inc. NDC 68180-353-09 D-0227-2026
Class II · Moderate risk Ongoing

OraVerse

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 0362-0101-10 D-0234-2026
Class II · Moderate risk Ongoing

Cook-Walte

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 0362-0753-05 D-0233-2026
Class II · Moderate risk Ongoing

Benco dental Graham CHEMICAL CO.

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66975-406-51 D-0232-2026
Class II · Moderate risk Ongoing

darby dental supply

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk Ongoing

3% Polocaine DENTAL

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026
Class II · Moderate risk Ongoing

Lidocaine HCI 2% and Epinephrine 1:100

Reason Defective container: cracked/broken cartridges

Novocol Pharmaceutical of Canada, Inc. NDC 50227-1030-5 D-0229-2026